1. Seidman H, Mushinski MH, Gelb SK, Silverberg E. Probabilities of eventually developing or dying of cancer: United States. Cancer J Clin 1985; 35: 36–56 (Abst).
2.  Coates M, Armstrong B. Cancer in NSW. Incidens and Mortality 1994;:58–9.
3.  Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. Cancer J Clin 1990; 44:7–26.
4.  Матвеев Б.П. Клиническая онкоурология 2003, с. 437–9.
5. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate cancer 1990;16:39–48.
6. Parkin DM, Muir CS, Whelan SL, Gao YT, et al. Cancer incidence in five Continents, vol. VI, IARC Scientific Publication, Lyon 1992; 20.
7. Boyle P, Maisonneuve P, Napalkov P. Incidece of prostate cancer will double by the year 2030: the argument for // Eur. Urol. – 1996. – Vol. 29. – Suppl. 2. – P. 3–9.
8. Заридзе Д.Г. Эпидемиология рака простаты. В материалах Европейской школы онкологов. «Рак простаты». Москва 1997. 
9. Holund B. Latent prostatic cancer in a consecutive autopsy series // Scand. J. Urol. Nephrol. – 1980. – Vol. 14. – P. 29. 
10. Yatani R, Kusano I, Shiraishi T, et al. Latent prostatic carcinoma: pathological and epidemiological aspects // Jpn. J. Clin. Oncol. – 1989. – Vol. 19. – P. 319–26. 
11. Smith JR, Freier D, Carpten J, et al. Major susceptibility locus for prostate cancer on chromosome I suggested by a genomic wide search // Science. – 1996. – Vol. 274. – P. 1371–3. 
12. Xu J, Schleutker J, Berry R, et al. Evidence for prostate cancer susceptibility locus on the X chromosome // Nat. Genet. – 1998. – Vol. 20. – P. 175–9.
13. Walsh PC, Partin AW. Family history facilitates the early diagnosis of prostate carcinoma // Cancer. – 1997. – Vol. 80.  P. 1871–4.
14.  Kaul L, Heshmat M, Kovi J, Jackson MA, Jackson MG, Jones GW, Enterline JP, Worrell RG, Perry SL. The role of diet in prostate cancer. Nutr Cancer 1987;9:123–8. 
15.  Denis, L., Morton, M. S., and Griffiths, K. (1999) Eur. Urol. 35, 377–87. 
16. Kolonel, L. N., Hankin, J. H., Whittemore, A. S., Wu, A. H., Gallagher, R. P., Wilkens, L. R., John, E. M., Howe, G. R., Dreon, D. M., West, D. W., and Paffenbarger, R. S., Jr. (2000) Cancer Epidemiol. Biomark. Prev. 9, 795–804. 
17. Aaron E.Katz, Erica Golliday BS. An overview of the existing scientific research on prostate cancer nutrition. 1999:Center for Holistic Urology P. 
18.  Kaul L, Heshmat M, Kovi J, Jackson MA, Jackson MG, Jones GW, Enterline JP, Worrell RG, Perry SL. The role of diet in prostate cancer. Nutr Cancer 1987;9:123–8.
19. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer // J. Natl. Cancer Inst. – 1995. – Vol. 87. – P. 1767–76.  
20. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer // Br. J. Cancer. – 1997. – Vol. 76. – P. – 678–87.
21. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and dietare carotinoids // Am. J. Epidemiol. – 2000. – Vol. 151. – P. 119–23.
22. J Clin Invest. 2003 March 1; 111(5): 583–93. © 2003, American Society for Clinical Investigation.Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. Lawrence J. Marnett, James N. Riggins, and James D. West].
23.  Biochem. J. (1996) 313, 17±29 (Printed in Great Britain) 17REVIEW ARTICLE Damage to DNA by reactive oxygen and nitrogen species : role in inflammatory disease and progression to cancer.  Helen WISEMAN* and Barry HALLIWELL. *Department of Nutrition and Dietetics, King's College London, Campden Hill Road, London W8 7AH, and Pharmacology Group, King's College London, Manresa Road, London SW3 6LX, U.K 
24. Е.Б. Мазо, В.В. Мешков. Простатическая интраэпителиальная неоплазия. Москва. Гэотар-мед. 2001. стр. 10–1. 
25. Н.Н. Мушкамбаров, С.Л. Кузнецов. Молекулярная биология. Медицинское информационное агенство. Москва 2003. стр. 501
26. Totter, J. R. (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 1763±1767 Ames, B. N. (1989) Free Radical Res. Commun. 7, 121±128 
27. Oshima, H. and Bartsch, H. (1994) Mutat. Res. 305, 253±264 Feig, D. I., Reid, T. M. and Loeb, L. A. (1994) Cancer Res. (Suppl.) 54, 1890s±1894s  Routledge, M. N., Wink, D. A., Keefer, L. K. and Dipple, A. (1994) Chem. Res Toxicol. 7, 628±632.   Biochem. J. (1996) 313, 1 7±29 (Printed in Great Britain) 17 REVIEW ARTICLE Damage to DNA by reactive oxygen and nitrogen species : role in inflammatory disease and progression to cancer Helen WISEMAN* and Barry HALLIWELL. *Department of Nutrition and Dietetics, King's College London, Campden Hill Road, London W8 7AH, and .Pharmacology Group, King's College  London, Manresa Road, London SW3 6LX, U.K. J Clin Invest. 2003 March 1; 111(5): 583-593.  doi: 10.1172/JCI200318022. © 2003, American Society for Clinical Investigation 
28. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. Lawrence J. Marnett, James N. Riggins, and James D. West. 
29. Bostwick DG, Brawer MK. Prostatic intraepithelial neoplasia and early invasion in prostate cancer // Cancer. – 1987. – Vol. 59. – P. 788–94. 
30. Coptocoat MJ. The management of advanced prostate cancer. – Boston: Blackwell Science, 1996. 
31. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate // Hum. Pathol. – 1986. – Vol. 17. – P. 64–71. 
32. Qian J, Wolan P, Bostwick DG. The extent and multicentriciti of high grade prostatic intraepithelial neoplasia in clinicaly localized prostatic adenocarcinoma // Hum. Pathol. – 1997. – Vol. 28, No. 2 – P. 143–8.
33. Davidson D, Bostwick DG, Qian J. Et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies // J. Urol. – 1995. – Vol. 154. – P. 1295–9. 
34. Berner A, Skjorten FJ, Fossa SD. Follow-up of prostatic intraepithelial neoplasia // Eur. Urol. – 1996. – Vol. 30. – P. 256–60.
35. Mazo EB, Meshkov VV, Moufagued ML, Bogdanova AA. Prostatic intraepithelial neoplasia in the patients with presence and suspicion of prostate cancer. An update on renal, bladder, prostate and testicular cancer. Abstract book. PACIOU VI. 12-14 Oct. 2000. – Rotterdam: De Doelen, 2000. – P. 136–7.
36. Qian J, Bostwick DG, Takahashi S. Et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization // Cancer Res. – 1995. – Vol. – P. 5408–14.
37. Valve EM, Nevalainen MT, Nurmi MJ. Et al. Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer // Lab. Invest. – 2001. – 81 No. 6. – P. 815–26. 
38. Colombel M, Symmans F, Gil S. et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers // Am. J. Pathol. – 1993. – Vol. 143. – P. 390–400. 
39. Montone KT, Tonaszewski JE. In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma // J. Clin. Lab. Anal. – 1993. – No. 7. – P. 188–95. 
40. Turkeri LN, Sakr WA, Wykes SM. et al. Comparative analysis of epidermal growth factor receptor gene expression and product in benign, premalignant and malignant prostatic tissue // Prostate. – 1994. – Vol. 25. – P. 199–205. 
41. Myers RB, Grizzle WE. Biomarker expression in prostatic intraepithelial neoplasia // Eur. Urol. – 1996. – Vol. 30. – P. 153–66. 
42. Ferguson J, Zincke H, Ellison E. et al. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy  // Urology. – 1994. – Vol. 44, No. 1. – P. 91–5.
43. Takayama H, Shin M, Nonomura N, et al. p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens from non-transition and transition zones // Jpn. J. Cancer. Res. – 2000. – Vol. 91. No. 9. – P. 941–7. 
44. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic nascularity in benign and malignant prostatic tissue // Hum. Pathol. – 1993. – Vol. 24, No. 2. – P. 220–6.
45. Montinori R, Galluzzi CM, Diamanti L, et al. Prostatic intraepithelial neoplasia: expression and localization of proliferating cell nuclear antigen (PCNA) in epithelial, endothelial and stromal nuclei // Virchows Arch. [A]. – 1993. – Vol. 422. – P. 185–92
46. Bostwick DG, Dousa MK, Crowford BG, Wollan PC. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma // Am. J. Surg. Pathol. – 1994. – Vol. 18. – P. 1240–6. 
47. Boag AH, Young ID. Increased expression of the 72-kD type IV collagenase in prostatic adenocarcinoma: demonstration by immunohistochemistry and in situ hybridization // Am. J. Pathol. – 1994. – Vol. 144. – P. 585–91.  
48. Mayagarden SJ, Novotny DB, Moul JW, et al. Evaluation of catepsin D and epidermal growth factor receptor in prostate carcinoma // Mod. Pathol. – 1994. – Vol. 7. – P. 930–6.